✦ LIBER ✦

Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines

✍ Scribed by Peterson, D. E.; Bensadoun, R.- J.; Roila, F.

Book ID: 125846348
Publisher: Oxford University Press
Year: 2011
Tongue: English
Weight: 91 KB
Volume: 22
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdr391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of oral and gastrointestinal

Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines

✍ Peterson, D. E.; Bensadoun, R.- J.; Roila, F. 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 67 KB

Management of febrile neutropenia: ESMO

Management of febrile neutropenia: ESMO Clinical Practice Guidelines

✍ de Naurois, J.; Novitzky-Basso, I.; Gill, M. J.; Marti, F. M.; Cullen, M. H.; Ro 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 152 KB

Management of cancer pain: ESMO Clinical

Management of cancer pain: ESMO Clinical Practice Guidelines

✍ Ripamonti, C. I.; Bandieri, E.; Roila, F. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 166 KB

Management of cancer pain: ESMO Clinical

Management of cancer pain: ESMO Clinical Practice Guidelines

✍ Ripamonti, C. I.; Santini, D.; Maranzano, E.; Berti, M.; Roila, F. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 507 KB

Management of chemotherapy extravasation

Management of chemotherapy extravasation: ESMO–EONS clinical practice guidelines

✍ J.A. Pérez Fidalgo; L. García Fabregat; A. Cervantes; A. Margulies; C. Vidall; F 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 585 KB

Clinical practice guidelines for the pre

Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis

✍ Edward B. Rubenstein; Douglas E. Peterson; Mark Schubert; Dorothy Keefe; Deborah 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

## BACKGROUND. Oral and gastrointestinal (GI) mucositis can affect up to 100% of patients undergoing high-dose chemotherapy and hematopoietic stem cell transplantation, 80% of patients with malignancies of the head and neck receiving radiotherapy, and a wide range of patients receiving chemotherap